Quiescent Tissue Stem Cells Evade Immune Surveillance

    February 2018 in “ Immunity ”
    Judith Agudo, Eun Sook Park, Samuel A. Rose, Eziwoma Alibo, Robert E. Sweeney, Maxime Dhainaut, Koichi S. Kobayashi, Ravi Sachidanandam, Alessia Baccarini, Miriam Mérad, Brian D. Brown
    TLDR Inactive stem cells in hair follicles and muscles can avoid detection by the immune system.
    The study concluded that quiescent tissue stem cells, particularly hair follicle stem cells (HFSCs) and muscle stem cells, evaded immune surveillance by downregulating MHC-I expression, a key component of the antigen presentation pathway. This immune evasion was linked to the transcription factor Foxc1 and the regulatory gene Nlrc5. Unlike fast-cycling stem cells, quiescent HFSCs and satellite cells avoided immune detection, which is crucial for tissue maintenance and repair. The findings suggested that this immune evasion mechanism could explain how hair follicles regenerate after immune attacks and might provide insights into how early cancer cells avoid immune surveillance.
    Discuss this study in the Community →

    Research cited in this study

    2 / 2 results

    Related Community Posts Join

    5 / 5 results

    Similar Research

    5 / 1000+ results
      The JAK/STAT Signaling Pathway: From Bench to Clinic

      research The JAK/STAT Signaling Pathway: From Bench to Clinic

      489 citations, November 2021 in “Signal Transduction and Targeted Therapy”
      The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.
      [object Object]

      research Pathogenesis and regenerative therapy in vitiligo and alopecia areata: focus on hair follicle

      January 2025 in “Frontiers in Medicine”
      The document examines the pathogenesis and regenerative therapies for vitiligo and alopecia areata (AA), focusing on hair follicles. It highlights the immune privilege of hair follicles, which protects stem cells from autoimmune attacks, and the potential for repigmentation therapy in vitiligo due to surviving melanocytes. In AA, the breakdown of follicular immune privilege leads to hair loss. The study discusses the role of hair follicle stem cells and dermal papilla cells in hair restoration, exploring the use of induced pluripotent stem cells and mesenchymal stem cells for bioengineering hair follicles. Treatments like JAK inhibitors and minoxidil show effectiveness for AA, while autologous hair follicle cell transplantation shows promise for vitiligo. The document emphasizes the complex immune mechanisms involved and suggests hair follicles as a focal point for therapeutic interventions, though challenges such as treatment unpredictability and adverse reactions remain.